Key upcoming milestones include expert discovery completion, scheduled for March 27, 2026
Get more Vitamin C
Patients should tell their provider about any personal or family history of medullary thyroid cancer, MEN 2, pancreatitis, gallbladder issues, kidney problems, diabetes medications, pregnancy, breastfeeding, or severe stomach/gastrointestinal conditions
Current FDA labeling states that routine calcitonin measurement or thyroid ultrasound is of uncertain value for early detection
Post-marketing surveillance has documented cases of inadvertent overdosing, typically involving administration errors where patients received higher-than-prescribed doses or more frequent injections than intended
Retrieved from Ludvik, B., Giorgino, F., Jdar, E., et al